Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome



Similar documents
In vitro co-culture model of the inflamed intestinal mucosa

Functional properties of fructans and their potential role in management of intestinal inflammatory pathologies

The Polyphenol Study. Effect of Dietary Polyphenols on Intestinal Microbiota, Intestinal Inflammation and Metabolic Syndrome

Migrene og mikroflora. Linda Mulder, MSc. Vårseminaret 2014

Introduction. Pathogenesis of type 2 diabetes

Probiotics for the Treatment of Adult Gastrointestinal Disorders

Research in IBD at University of Colorado Denver

Give a NOD to diabetes:

Symptomspesifikke probiotikum. Linda Mulder, MSc. Vårseminaret 2014

Autoimmunity and immunemediated. FOCiS. Lecture outline

Bile Duct Diseases and Problems

Hapten - a small molecule that is antigenic but not (by itself) immunogenic.

1) Aug 2005 In Vitro Chromosomal Aberration Study Cytotoxicity (File: TS39) Conclusion No cytotoxicity can be detected at concentrations up to 100%.

Definition: What is the Microbiome- A Big Picture

Microscopic Colitis: Collagenous Colitis and Lymphocytic Colitis

DiAgRaMs- RAAK PRO. Shirley Kartaram

Principles of Disease and Epidemiology. Copyright 2010 Pearson Education, Inc.

Nutrition and Toxicants in Autoimmune Disease: Implications for Prevention and Treatment

Restore and Maintain treatment protocol

A link between gut microbiota, mucosal immunity and autoimmune arthritis. Hsin-Jung Joyce Wu "Microbiota and man: the story about us

Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine

Canadian Microbiome Initiative

July 30, Probable Link Evaluation of Autoimmune Disease

Basic Overview of Preclinical Toxicology Animal Models

Basics of Immunology

A disease and antibody biology approach to antibody drug discovery

IBS TREATMENT CENTER

Summary and conclusion 2013

Pulmonary interstitium. Interstitial Lung Disease. Interstitial lung disease. Interstitial lung disease. Causes.

TREATING INFLAMMATORY BOWEL DISEASE (IBD) BACKGROUNDER

Rheumatoid arthritis: an overview. Christine Pham MD

Mini-Medical School on Infectious Diseases. Session #1 - Basic Science

Arthritis and Rheumatology Clinics of Kansas Patient Education. Reactive Arthritis (ReA) / Inflammatory Bowel Disease (IBD) Arthritis

JIANGSU CARTMAY INDUSTRIAL CO.,LTD mail:

Alcohol and Brain Damage

PROPOSED. State of California AIR RESOURCES BOARD

An Overview of Cells and Cell Research

Pharmacology of the Respiratory Tract: COPD and Steroids

Drug Development Services

GUIDELINES FOR THE REGISTRATION OF BIOLOGICAL PEST CONTROL AGENTS FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS

Diseases of peritoneum Lect. Al Qassim University, Faculty of Medicine Phase II Year III, CMD 332 Pathology Department 31-32

Personal Injury TYPES OF HOLIDAY ILLNESSES. Telephone

Worms for Your Health --

Subproject 4: Specification and Documentation of Metabolic and Neoplastic Diseases

This year, I began my term of office as the new

1) Siderophores are bacterial proteins that compete with animal A) Antibodies. B) Red blood cells. C) Transferrin. D) White blood cells. E) Receptors.

Vitamin D deficiency exacerbates ischemic cell loss and sensory motor dysfunction in an experimental stroke model

Understanding Colitis and Crohn s Disease

PROBIOTICS. what they are and what they can do for you. A patient s guide from your doctor and

CHAPTER 2 ANTIGEN/ANTIBODY INTERACTIONS

Pre-Budget Consultation Submission to the Standing Committee on Finance. August 6 th, 2014

Irritable Bowel Syndrome

Leukapheresis for inflammatory bowel disease

What Is Clostridium Difficile (C. Diff)? CLOSTRIDIUM DIFFICILE (C. DIFF)

EVIDENCE BASED TREATMENT OF CROHN S DISEASE. Dr E Ndabaneze

Develop an understanding of the differential diagnosis of pseudomembranous colitis

Natalia Taborda Vanegas. Doc. Sci. Student Immunovirology Group Universidad de Antioquia

Protein electrophoresis is used to categorize globulins into the following four categories:

PART B: METHODS FOR THE DETERMINATION OF TOXICITY AND OTHER HEALTH EFFECTS GENERAL INTRODUCTION: PART B

Crohn's and Colitis UK Information Sheet. Students with IBD: a guide for universities and colleges

C. difficile Infections

19/03/2012 Toxicologicalcharacterizationof PM10: case study Genk-Zuid. R. Van Den Heuvel

It s A Gut Feeling: Abdominal Pain in Children. David Deutsch, MD Pediatric Gastroenterology Rockford Health Physicians

Probiotics for Gut Health

Study of Effects of Probiotic Lactobacilli in Preventing Major Complications in Patients of Liver Cirrhosis

Antibiotic-Associated Diarrhea, Clostridium difficile- Associated Diarrhea and Colitis

ELISA BIO 110 Lab 1. Immunity and Disease

Crohn s Disease. What is Crohn s Disease? ho gets Crohn s Disease? hat are the symptoms? What causes Crohn s Disease?

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Multiple Technology Appraisal

Functional Analysis of the Interleukin-10 (IL-10) Network by Induction of Colitis in Conditional IL-10 and IL-10 Receptor Knock-Out Mice

Clostridium Difficile Colitis. Presented by Mark Skains August 2003

Making the switch to a safer CAR-T cell therapy

Bacterial Transformation Post lab Questions:

Key words: Vitamin D Production, Vitamin D Deficiency, and Vitamin D Treatment

As Reported by the Senate Health, Human Services and Aging Committee. 127th General Assembly Regular Session Sub. S. B. No A B I L L

International Aloe Science Council Certified Facility and Products

What is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:

2013 Indiana Healthcare Provider and Hospital Administrator Multi-Drug Resistant Organism Survey

FINAL REPORT For Japan-Korea Joint Research Project AREA

More information >>> HERE <<<

NICE guideline Published: 2 September 2015 nice.org.uk/guidance/ng20

Normal and Abnormal Aging and the Brain. Joel Kramer, PsyD Saul Villeda, PhD Kristine Yaffe, MD

The Human Genome Project. From genome to health From human genome to other genomes and to gene function Structural Genomics initiative

Frequently Asked Questions: Ai-Detox

SYNERGISTIC ROLE OF IL-15 IN THE EPITHELIUM AND THE LAMINA PROPRIA IN CELIAC DISEASE PATHOGENESIS

Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007

Chapter 18: Applications of Immunology

Transcription:

Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome Andrew T. Gewirtz et al N A T U R E VOL 519 5 M A R C H 2 0 1 5

Background Incidence of IBD Fact 1: increasing in the past decades worldwide Fact 2: markedly higher in developed western countries Journal Club 22.04.2015 / Ioannis Linas 2

Background Incidence of IBD Fact 1: increasing in the past decades worldwide Fact 2: markedly higher in developed western countries Chron s disease V. Loftus, Jr. Clinical Epidemiology of Inflammatory Bowel Disease: Incidence, Prevalence, and Environmental Influences, Edward. Gastroenterology 2004;126:1504 1517 Journal Club 22.04.2015 / Ioannis Linas 3

Background Incidence of IBD Fact 1: increasing in the past decades worldwide Fact 2: markedly higher in developed western countries Ulcerative colitis V. Loftus, Jr. Clinical Epidemiology of Inflammatory Bowel Disease: Incidence, Prevalence, and Environmental Influences, Edward. Gastroenterology 2004;126:1504 1517 Journal Club 22.04.2015 / Ioannis Linas 4

Journal Club 22.04.2015 / Ioannis Linas 5

Role of Microbiota Background Fact 3: gut microbiota provides important benefits: metabolism / immune development Fact 4: disturbance of the microbiota host relationship: numerous chronic inflammatory diseases (IBD and metabolic syndrome) Fact 5: multi-layered mucus structures regulate this interaction Journal Club 22.04.2015 / Ioannis Linas 6

Hypothesis Agents that disrupt mucus bacterial interactions might promote gut inflammation Fact 6: Emulsifiers can increase bacterial translocation across epithelia in vitro Emulsifiers Microbiota Host Interaction Colitis Roberts, C. L. et al. Translocation of Crohn s disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers. Gut 59, 1331 1339 (2010). Journal Club 22.04.2015 / Ioannis Linas 7

Methods 1. wild-type C57Bl/6 2. two engineered strains (IL10 -/- and Tlr5 -/- ) 3. Germ free mice carboxymethylcellulose(cmc) or polysorbate-80 (P80) via drinking water (1.0% w/v or v/v, resp.) for 12 weeks. *P80: FDA approved at up to 1.0%. * CMC deemed generally regarded as safe (GRAS) used at up to 2.0% Journal Club 22.04.2015 / Ioannis Linas 8

Endpoints and Results Microbiota encroachment of the epithelium Wild Type, Water closest bacteria 25 μm from epithelial cells no bacteria within 10 μm Wild Type Emulsifier treated average distance reduced > 50% bacteria in contact with the epithelium IL10 -/- and Tlr5 -/- basal microbiota encroachment enhanced by both CMC and P80 Journal Club 22.04.2015 / Ioannis Linas 9

Confocal microscopy + mucus-preserving Carnoy fixation Journal Club 22.04.2015 / Ioannis Linas 10

Microbiota composition Endpoints and Results Both CMC and P80 dramatically altered composition of both faecal and intestinal-adherent microbiota in in all groups. reduced levels of Bacteroidales / increased levels of bacteria with mucolytic properties marked reduction in microbial diversity Journal Club 22.04.2015 / Ioannis Linas 11

Endpoints and Results Increase in colonic adherent bacteria Journal Club 22.04.2015 / Ioannis Linas 12

Endpoints and Results Pro inflammatory activity in faeces Exposure to emulsifiers increased faecal levels of bioactive lipopolysaccharide LPS and flagellin in all groups * lipopolysaccharide (LPS) and flagellin receptors TLR4 and TLR5 activate pro-inflammatory gene expression Journal Club 22.04.2015 / Ioannis Linas 13

Endpoints and Results Gut permeability Emulsifier treatment increased gut permeability in wild-type and Il10-/-mice *increased levels of serum antibodies to flagellin and LPS correlate with permeability Ziegler, T. R. et al. Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndrome. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R402 R410 (2008). Journal Club 22.04.2015 / Ioannis Linas 14

Conclusion 1 exposure to dietary emulsifiers results in erosion of the protective function of the mucus, increased bacterial adherence and a more pro-inflammatory microbiota Journal Club 22.04.2015 / Ioannis Linas 15

Conclusion 1 exposure to dietary emulsifiers results in erosion of the protective function of the mucus, increased bacterial adherence and a more pro-inflammatory microbiota Emulsifiers Microbiota Host Interaction Journal Club 22.04.2015 / Ioannis Linas 16

Conclusion 1 exposure to dietary emulsifiers results in erosion of the protective function of the mucus, increased bacterial adherence and a more pro-inflammatory microbiota Emulsifiers Microbiota Host Interaction Colitis??? Journal Club 22.04.2015 / Ioannis Linas 17

Features of colitis Endpoints and Results the presence of immune cell infiltrates changes in gross colon morphology elevated levels of the leukocyte myeloperoxidase Faecal lipocalin 2 (LCN2) Il10-/- and Tlr5-/-: promoted extent and incidence of colitis, 10fold increase in LCN2 wild-type: subtle histopathologic changes, modest increase in LCN2 Journal Club 22.04.2015 / Ioannis Linas 18

Conclusion 2 emulsifiers may promote robust colitis in susceptible hosts and induce low-grade inflammation in wild-type hosts Journal Club 22.04.2015 / Ioannis Linas 19

Conclusion 2 emulsifiers may promote robust colitis in susceptible hosts and induce low-grade inflammation in wild-type hosts Emulsifiers Microbiota Host Interaction Journal Club 22.04.2015 / Ioannis Linas 20

Conclusion 2 emulsifiers may promote robust colitis in susceptible hosts and induce low-grade inflammation in wild-type hosts Emulsifiers Colitis Journal Club 22.04.2015 / Ioannis Linas 21

Conclusion 2 emulsifiers may promote robust colitis in susceptible hosts and induce low-grade inflammation in wild-type hosts Emulsifiers Microbiota Host Interaction Colitis Journal Club 22.04.2015 / Ioannis Linas 22

Microbiota required? Endpoints and Results Emulsifier treated germ free mice No change in LCN2, Colon length, no splenomegaly No reduction in mucus structure Transfer of microbiota from emulsifier-treated mice to germ-free mice microbiota encroachment, low grade inflammation elevated levels of faecal LPS and flagellin altered microbiota composition Journal Club 22.04.2015 / Ioannis Linas 23

Conclusion 3 emulsifier-induced changes in the microbiota have a role in driving the inflammation and metabolic changes promoted by these food additives Journal Club 22.04.2015 / Ioannis Linas 24

Conclusion 3 emulsifier-induced changes in the microbiota have a role in driving the inflammation and metabolic changes promoted by these food additives Emulsifiers Microbiota Host Interaction Colitis Journal Club 22.04.2015 / Ioannis Linas 25

Discussion Steady increase in the consumption of food additives, many of which have not been carefully tested Testing has used animal models designed to detect acute toxicity and/or promotion of cancer Emulsifiers, can disturb the host microbiota relationship and thus promote intestinal inflammation, which can manifest as colitis or metabolic syndrome. Dietary emulsifiers may have contributed to the post-midtwentieth-century increase in incidence of inflammatory bowel disease and metabolic syndrome Journal Club 22.04.2015 / Ioannis Linas 26

Limitations Animal model study Continuous exposition to emulsifier Withdrawal effect? Overall Provides possible explanations for epidemiologic data Proves Hypothesis step by step Excludes interfering factors Journal Club 22.04.2015 / Ioannis Linas 27

Thank you for your attention Journal Club 22.04.2015 / Ioannis Linas 28